News
-
-
-
-
PRESS RELEASE
2024-2025 half-year results / Recurring operating margin at 9.1%, up 80 bps / Operating FCF positive at EUR 9.4 million / Improvement in financial leverage / upward revision of recurring operating margin target to 9.1%
Groupe Bastide, a leading home healthcare services provider, announces 2024-2025 half-year financial results. Revenue grows by 4.0% with organic growth of 8.5% -
-
-
PRESS RELEASE
Organic growth of 8.4% in first-half 2024 2025: Home healthcare services up 10.2% and Return to growth in the Homecare business / 2024-2025 targets confirmed
Groupe Bastide reports €275.2 million revenue for H1 2024-2025, with 8.6% growth. Confirms full-year revenue target of €560 million with a recurring operating margin goal of at least 8.7% -
-
-
PRESS RELEASE
BASTIDE obtains an extended license to operate in Canada in the Respiratory Care segment / Sale of French stomatherapy subsidiary CICA PLUS
Groupe Bastide extends respiratory care license to British Columbia, Canada, while selling French subsidiary CICA PLUS specialized in stomatherapy. The company aims to boost organic growth in Canada and improve financials
